US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Genprex, Inc.

3.35

0.0000

Post-market: 3.32-0.0300-0.90%19:40 EDT

Volume:28.16K

Turnover:95.14K

Market Cap:2.75M

PE:-0.02

High:3.43

Open:3.39

Low:3.33

Close:3.35

52wk High:1,210.00

52wk Low:3.31

Shares:819.70K

Float Shares:818.70K

Volume Ratio:0.82

T/O Rate:3.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-173.0075

EPS(LYR):-382.7870

ROE:-203.86%

ROA:-94.46%

PB:0.19

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Genprex faces Nasdaq delisting risk after bid price stays below $1

Genprex files $250M mixed securities shelf

Genprex Inc Files for Mixed Shelf of up to $250 Mln – SEC Filing

THOMSON REUTERS

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 Asco Annual Meeting

THOMSON REUTERS

Genprex collaborators present positive preclinical data of GPX-002 in diabetes

Genprex Q1 net loss widens 13% to $4.46 million year over year

Genprex Receives Patent Grant From the Israel Patent Office for the Combination of Reqorsa® Gene Therapy and Pd-1 Antibodies to Treat Cancer

THOMSON REUTERS

Genprex says Israel grants patent for Reqorsa plus PD-1 antibody cancer treatment combo

Genprex says diabetes gene therapy reverses hyperglycemia in preclinical Type 2 models

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy to Be Released at the 2026 Asco Annual Meeting

THOMSON REUTERS

Genprex signs MD Anderson research deal to study Reqorsa lung cancer response biomarkers

Genprex Signs Sponsored Research Agreement to Study Biomarkers That May Predict Patient Response to Reqorsa® Gene Therapy

THOMSON REUTERS

Genprex says Reqorsa gene therapy data support potential ALK+ NSCLC clinical trial

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 Aacr Annual Meeting

THOMSON REUTERS

Genprex announces annual shareholder meeting webcast

Genprex director Brent Longnecker disposes of USD 22 common shares

Genprex FY25 net loss narrows 23% to $16M

Genprex collaborators to present Reqorsa lung cancer preclinical data at AACR 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/GNPX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNPX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNPX\",,,,,undefined,":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":3.35,"timestamp":1789156800000,"preClose":3.35,"halted":0,"volume":28159,"hourTrading":{"tag":"盘后","latestPrice":3.32,"preClose":3.35,"latestTime":"19:40 EDT","volume":678,"amount":2276.55,"timestamp":1789170026156,"change":-0.03,"changeRate":-0.008955,"amplitude":0.008955},"delay":0,"changeRate":0,"floatShares":818700,"shares":819700,"eps":-173.0075,"marketStatus":"Market Closed","change":0,"latestTime":"09-11 16:00:00 EDT","open":3.39,"high":3.43,"low":3.33,"amount":95135.99247920001,"amplitude":0.029851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-173.0075,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1522296000000,"exchange":"NASDAQ","adjPreClose":3.35,"preHourTrading":{"tag":"盘前","latestPrice":3.36,"preClose":3.35,"latestTime":"08:44 EDT","volume":150,"amount":510.354,"timestamp":1789130660388,"change":0.01,"changeRate":0.002985,"amplitude":0.041612},"postHourTrading":{"tag":"盘后","latestPrice":3.32,"preClose":3.35,"latestTime":"19:40 EDT","volume":678,"amount":2276.55,"timestamp":1789170026156,"change":-0.03,"changeRate":-0.008955,"amplitude":0.008955},"volumeRatio":0.820483682983683,"impliedVol":3.1839,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNPX\",,,,,undefined,":{"symbol":"GNPX","floatShares":818700,"roa":"-94.46%","roe":"-203.86%","lyrEps":-382.787042,"volumeRatio":0.820483682983683,"shares":819700,"dividePrice":0,"high":3.43,"amplitude":0.029851,"preClose":3.35,"low":3.33,"week52Low":3.31,"pbRate":"0.19","week52High":1210,"institutionHeld":0,"latestPrice":3.35,"eps":-173.0075,"divideRate":0,"volume":28159,"delay":0,"ttmEps":-173.0075,"open":3.39,"prevYearClose":38.5,"prevWeekClose":3.5,"prevMonthClose":3.71,"prevQuarterClose":11.418,"fiveDayClose":3.425,"twentyDayClose":4.87,"sixtyDayClose":9.5854},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNPX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"GNPX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-9.4},{"market":"US","date":"2026-07-16","symbol":"GNPX","defaultRemindTime":1784208600000,"type":"split","dateTimestamp":1784174400000,"forFactor":22,"toFactor":1,"ratio":22},{"market":"US","date":"2026-05-13","symbol":"GNPX","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2026-03-30","symbol":"GNPX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-14","symbol":"GNPX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNPX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNPX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GNPX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GNPX","date":"2026-09-11","current":-0.019363,"percent":0.876634,"low":-8.741506,"twenty":-3.459762,"median":-0.465781,"eighty":-0.220717,"high":-0.045425,"avg":-1.638744,"sd":1.886061,"marketCap":2746025},"quantilePoints":[{"date":"2021-09-17","current":-7.330145,"twenty":-10.798701,"median":-7.306975,"eighty":-1.826473,"marketCap":135454392},{"date":"2021-09-24","current":-7.175826,"twenty":-10.767587,"median":-7.298278,"eighty":-1.833664,"marketCap":132602721},{"date":"2021-10-01","current":-6.944348,"twenty":-10.758048,"median":-7.28958,"eighty":-1.835462,"marketCap":128325213},{"date":"2021-10-08","current":-6.352792,"twenty":-10.72838,"median":-7.280446,"eighty":-1.835462,"marketCap":117393806},{"date":"2021-10-15","current":-6.198473,"twenty":-10.698418,"median":-7.255341,"eighty":-1.848012,"marketCap":114542135},{"date":"2021-10-22","current":-5.889836,"twenty":-10.66998,"median":-7.246475,"eighty":-1.885526,"marketCap":108838792},{"date":"2021-10-29","current":-5.992715,"twenty":-10.664292,"median":-7.21558,"eighty":-1.897394,"marketCap":110739906},{"date":"2021-11-05","current":-5.581198,"twenty":-10.571434,"median":-7.175826,"eighty":-1.899493,"marketCap":103135449},{"date":"2021-11-12","current":-5.324,"twenty":-10.54822,"median":-7.149395,"eighty":-1.911083,"marketCap":98382663},{"date":"2021-11-19","current":-4.345777,"twenty":-10.506027,"median":-7.110869,"eighty":-1.9139,"marketCap":83186911},{"date":"2021-11-26","current":-3.946166,"twenty":-10.495479,"median":-7.071943,"eighty":-1.923313,"marketCap":75537540},{"date":"2021-12-03","current":-3.321772,"twenty":-10.494401,"median":-7.032575,"eighty":-1.935366,"marketCap":63585398},{"date":"2021-12-10","current":-3.671432,"twenty":-10.4772,"median":-6.999197,"eighty":-1.959512,"marketCap":70278597},{"date":"2021-12-17","current":-3.446651,"twenty":-10.466212,"median":-6.995787,"eighty":-1.993335,"marketCap":65975826},{"date":"2021-12-23","current":-3.596505,"twenty":-10.456822,"median":-6.982927,"eighty":-2.006865,"marketCap":68844340},{"date":"2021-12-31","current":-3.271821,"twenty":-10.432189,"median":-6.940675,"eighty":-2.007267,"marketCap":62629226},{"date":"2022-01-07","current":-5.544612,"twenty":-10.415963,"median":-6.937002,"eighty":-2.00787,"marketCap":106135025},{"date":"2022-01-14","current":-5.644515,"twenty":-10.412554,"median":-6.869229,"eighty":-2.011978,"marketCap":108047368},{"date":"2022-01-21","current":-4.545583,"twenty":-10.405766,"median":-6.830954,"eighty":-2.019255,"marketCap":87011597},{"date":"2022-01-28","current":-4.570559,"twenty":-10.394679,"median":-6.815749,"eighty":-2.026852,"marketCap":87489683},{"date":"2022-02-04","current":-5.494661,"twenty":-10.391334,"median":-6.786437,"eighty":-2.04254,"marketCap":105178854},{"date":"2022-02-11","current":-5.61954,"twenty":-10.384722,"median":-6.764309,"eighty":-2.057219,"marketCap":107569282},{"date":"2022-02-18","current":-5.519637,"twenty":-10.358352,"median":-6.660476,"eighty":-2.066743,"marketCap":105656939},{"date":"2022-02-25","current":-5.569588,"twenty":-10.337255,"median":-6.635549,"eighty":-2.070777,"marketCap":106613111},{"date":"2022-03-04","current":-5.344806,"twenty":-10.337255,"median":-6.597859,"eighty":-2.076582,"marketCap":102310339},{"date":"2022-03-11","current":-5.269879,"twenty":-10.298955,"median":-6.585551,"eighty":-2.109687,"marketCap":100876082},{"date":"2022-03-18","current":-6.069103,"twenty":-10.258144,"median":-6.558551,"eighty":-2.11784,"marketCap":116174825},{"date":"2022-03-25","current":-5.919248,"twenty":-10.231773,"median":-6.532831,"eighty":-2.134802,"marketCap":113306310},{"date":"2022-04-01","current":-5.448755,"twenty":-10.226597,"median":-6.495202,"eighty":-2.14736,"marketCap":106771748},{"date":"2022-04-08","current":-5.033379,"twenty":-10.222017,"median":-6.428566,"eighty":-2.159223,"marketCap":98632198},{"date":"2022-04-14","current":-4.862342,"twenty":-10.208726,"median":-6.373813,"eighty":-2.163768,"marketCap":95280618},{"date":"2022-04-22","current":-4.275929,"twenty":-10.203063,"median":-6.301353,"eighty":-2.177454,"marketCap":83789489},{"date":"2022-04-29","current":-3.909829,"twenty":-10.193702,"median":-6.197764,"eighty":-2.180591,"marketCap":76615532},{"date":"2022-05-06","current":-3.738774,"twenty":-10.181527,"median":-6.135392,"eighty":-2.190173,"marketCap":73263603},{"date":"2022-05-13","current":-3.866792,"twenty":-10.178493,"median":-6.056629,"eighty":-2.195537,"marketCap":72805493},{"date":"2022-05-20","current":-3.841353,"twenty":-10.144926,"median":-6.018435,"eighty":-2.196279,"marketCap":72326510},{"date":"2022-05-27","current":-3.815913,"twenty":-10.13141,"median":-5.968469,"eighty":-2.196763,"marketCap":71847526},{"date":"2022-06-03","current":-3.790474,"twenty":-10.127823,"median":-5.931736,"eighty":-2.196884,"marketCap":71368542},{"date":"2022-06-10","current":-3.612398,"twenty":-10.114116,"median":-5.915556,"eighty":-2.204416,"marketCap":68015658},{"date":"2022-06-17","current":-3.332564,"twenty":-10.102352,"median":-5.892055,"eighty":-2.209864,"marketCap":62746839},{"date":"2022-06-24","current":-3.561519,"twenty":-10.092603,"median":-5.866707,"eighty":-2.210876,"marketCap":67057691},{"date":"2022-07-01","current":-3.51064,"twenty":-10.078396,"median":-5.844321,"eighty":-2.213751,"marketCap":66099724},{"date":"2022-07-08","current":-3.637837,"twenty":-10.069671,"median":-5.769394,"eighty":-2.218672,"marketCap":68494641},{"date":"2022-07-15","current":-3.663277,"twenty":-10.049506,"median":-5.706955,"eighty":-2.227654,"marketCap":68973625},{"date":"2022-07-22","current":-3.586959,"twenty":-10.029049,"median":-5.694467,"eighty":-2.227654,"marketCap":67536674},{"date":"2022-07-29","current":-3.53608,"twenty":-10.021472,"median":-5.676784,"eighty":-2.227905,"marketCap":66578707},{"date":"2022-08-05","current":-3.637837,"twenty":-10.020809,"median":-5.669491,"eighty":-2.230011,"marketCap":68494641},{"date":"2022-08-12","current":-4.247333,"twenty":-10.017548,"median":-5.651436,"eighty":-2.234588,"marketCap":84995938},{"date":"2022-08-19","current":-4.799246,"twenty":-10.000269,"median":-5.644515,"eighty":-2.235264,"marketCap":96040608},{"date":"2022-08-26","current":-4.487295,"twenty":-9.980272,"median":-5.639221,"eighty":-2.235844,"marketCap":89797968},{"date":"2022-09-02","current":-3.887389,"twenty":-9.968068,"median":-5.61954,"eighty":-2.238194,"marketCap":77792892},{"date":"2022-09-09","current":-4.223337,"twenty":-9.968068,"median":-5.581198,"eighty":-2.23831,"marketCap":84515735},{"date":"2022-09-16","current":-3.767408,"twenty":-9.91647,"median":-5.544612,"eighty":-2.247098,"marketCap":75391877},{"date":"2022-09-23","current":-3.383468,"twenty":-9.888956,"median":-5.522056,"eighty":-2.249454,"marketCap":67708628},{"date":"2022-09-30","current":-3.383468,"twenty":-9.862585,"median":-5.519637,"eighty":-2.25903,"marketCap":67708628},{"date":"2022-10-07","current":-3.287484,"twenty":-9.861864,"median":-5.494661,"eighty":-2.25903,"marketCap":65787816},{"date":"2022-10-14","current":-3.191499,"twenty":-9.836215,"median":-5.47363,"eighty":-2.259652,"marketCap":63867004},{"date":"2022-10-21","current":-3.071518,"twenty":-9.836215,"median":-5.444709,"eighty":-2.260379,"marketCap":61465989},{"date":"2022-10-28","current":-3.383468,"twenty":-9.816568,"median":-5.347983,"eighty":-2.260379,"marketCap":67708628},{"date":"2022-11-04","current":-3.167502,"twenty":-9.816568,"median":-5.344806,"eighty":-2.260379,"marketCap":63386801},{"date":"2022-11-11","current":-3.335476,"twenty":-9.816568,"median":-5.321915,"eighty":-2.260379,"marketCap":66748222},{"date":"2022-11-18","current":-2.713233,"twenty":-9.805788,"median":-5.269879,"eighty":-2.263422,"marketCap":61472414},{"date":"2022-11-25","current":-2.734431,"twenty":-9.793914,"median":-5.195401,"eighty":-2.266011,"marketCap":61952667},{"date":"2022-12-02","current":-2.776825,"twenty":-9.788025,"median":-5.174979,"eighty":-2.271681,"marketCap":62913174},{"date":"2022-12-09","current":-2.681438,"twenty":-9.784238,"median":-5.14919,"eighty":-2.273037,"marketCap":60752034},{"date":"2022-12-16","current":-2.501262,"twenty":-9.783474,"median":-5.120025,"eighty":-2.274386,"marketCap":56669882},{"date":"2022-12-23","current":-2.119714,"twenty":-9.780257,"median":-5.120025,"eighty":-2.266011,"marketCap":48025324},{"date":"2022-12-30","current":-3.073585,"twenty":-9.779453,"median":-5.093623,"eighty":-2.265364,"marketCap":69636719},{"date":"2023-01-06","current":-3.03119,"twenty":-9.770513,"median":-5.045098,"eighty":-2.26917,"marketCap":68676213},{"date":"2023-01-13","current":-3.03119,"twenty":-9.746555,"median":-5.039238,"eighty":-2.272987,"marketCap":68676213},{"date":"2023-01-20","current":-2.771102,"twenty":-9.727712,"median":-5.005179,"eighty":-2.273393,"marketCap":62783506},{"date":"2023-01-27","current":-2.840416,"twenty":-9.715331,"median":-4.970171,"eighty":-2.274717,"marketCap":64353934},{"date":"2023-02-03","current":-3.62471,"twenty":-9.69636,"median":-4.953595,"eighty":-2.274717,"marketCap":82123304},{"date":"2023-02-10","current":-3.264359,"twenty":-9.624923,"median":-4.920219,"eighty":-2.274717,"marketCap":73958998},{"date":"2023-02-17","current":-3.62471,"twenty":-9.618667,"median":-4.866305,"eighty":-2.276872,"marketCap":82123304},{"date":"2023-02-24","current":-2.882811,"twenty":-9.59888,"median":-4.853817,"eighty":-2.285494,"marketCap":65314440},{"date":"2023-03-03","current":-2.615162,"twenty":-9.582151,"median":-4.815789,"eighty":-2.297312,"marketCap":59250448},{"date":"2023-03-10","current":-2.065748,"twenty":-9.55969,"median":-4.781926,"eighty":-2.297312,"marketCap":46802657},{"date":"2023-03-17","current":-1.777392,"twenty":-9.551256,"median":-4.751254,"eighty":-2.274717,"marketCap":40269515},{"date":"2023-03-24","current":-2.064601,"twenty":-9.546139,"median":-4.703273,"eighty":-2.266658,"marketCap":46776670},{"date":"2023-03-31","current":-2.087312,"twenty":-9.544825,"median":-4.625539,"eighty":-2.260379,"marketCap":47291213},{"date":"2023-04-06","current":-1.835201,"twenty":-9.477575,"median":-4.588917,"eighty":-2.257115,"marketCap":41579262},{"date":"2023-04-14","current":-1.854292,"twenty":-9.391461,"median":-4.500911,"eighty":-2.235264,"marketCap":44022044},{"date":"2023-04-21","current":-2.408171,"twenty":-9.372825,"median":-4.45103,"eighty":-2.227654,"marketCap":57171485},{"date":"2023-04-28","current":-1.798466,"twenty":-9.339055,"median":-4.343318,"eighty":-2.213847,"marketCap":42696705},{"date":"2023-05-05","current":-1.72792,"twenty":-9.292981,"median":-4.275929,"eighty":-2.196642,"marketCap":41021888},{"date":"2023-05-12","current":-1.780029,"twenty":-9.240822,"median":-4.204554,"eighty":-2.175296,"marketCap":42258990},{"date":"2023-05-19","current":-1.663988,"twenty":-9.160106,"median":-4.127352,"eighty":-2.151109,"marketCap":39504099},{"date":"2023-05-26","current":-1.59886,"twenty":-9.027812,"median":-4.080458,"eighty":-2.119714,"marketCap":44182216},{"date":"2023-06-02","current":-1.756865,"twenty":-8.976535,"median":-4.071044,"eighty":-2.094469,"marketCap":48548458},{"date":"2023-06-09","current":-1.698553,"twenty":-8.916846,"median":-4.012381,"eighty":-2.071201,"marketCap":46937107},{"date":"2023-06-16","current":-1.599236,"twenty":-8.860505,"median":-3.982287,"eighty":-2.060797,"marketCap":44192612},{"date":"2023-06-23","current":-1.45026,"twenty":-8.813799,"median":-3.963765,"eighty":-2.01972,"marketCap":40075869},{"date":"2023-06-30","current":-1.542429,"twenty":-8.763841,"median":-3.933678,"eighty":-2.00787,"marketCap":42622843},{"date":"2023-07-07","current":-1.604315,"twenty":-8.740526,"median":-3.886391,"eighty":-1.960912,"marketCap":44332955},{"date":"2023-07-14","current":-1.561804,"twenty":-8.639414,"median":-3.843275,"eighty":-1.927191,"marketCap":43158228},{"date":"2023-07-21","current":-1.627075,"twenty":-8.609679,"median":-3.815913,"eighty":-1.899813,"marketCap":44961902},{"date":"2023-07-28","current":-1.512142,"twenty":-8.570756,"median":-3.790474,"eighty":-1.859059,"marketCap":41785898},{"date":"2023-08-04","current":-1.571587,"twenty":-8.520384,"median":-3.771335,"eighty":-1.835462,"marketCap":43428579},{"date":"2023-08-11","current":-1.38046,"twenty":-8.490003,"median":-3.751893,"eighty":-1.822679,"marketCap":38147046},{"date":"2023-08-18","current":-1.177723,"twenty":-8.477195,"median":-3.739595,"eighty":-1.805771,"marketCap":32544700},{"date":"2023-08-25","current":-0.911773,"twenty":-8.477195,"median":-3.714156,"eighty":-1.796113,"marketCap":27215639},{"date":"2023-09-01","current":-1.034378,"twenty":-8.477195,"median":-3.688716,"eighty":-1.788747,"marketCap":30875284},{"date":"2023-09-08","current":-1.00711,"twenty":-8.47978,"median":-3.671432,"eighty":-1.784421,"marketCap":30061369},{"date":"2023-09-15","current":-1.025223,"twenty":-8.482366,"median":-3.663277,"eighty":-1.779269,"marketCap":30601999},{"date":"2023-09-22","current":-0.855447,"twenty":-8.482366,"median":-3.637837,"eighty":-1.759498,"marketCap":25534341},{"date":"2023-09-29","current":-0.756527,"twenty":-8.482366,"median":-3.612398,"eighty":-1.749089,"marketCap":22581673},{"date":"2023-10-06","current":-0.736425,"twenty":-8.482366,"median":-3.599435,"eighty":-1.731376,"marketCap":21981634},{"date":"2023-10-13","current":-0.655816,"twenty":-8.482366,"median":-3.586959,"eighty":-1.702418,"marketCap":19575536},{"date":"2023-10-20","current":-0.615014,"twenty":-8.484951,"median":-3.591732,"eighty":-1.691713,"marketCap":18357634},{"date":"2023-10-27","current":-0.423324,"twenty":-8.49247,"median":-3.599435,"eighty":-1.68314,"marketCap":12635843},{"date":"2023-11-03","current":-0.498988,"twenty":-8.49247,"median":-3.599435,"eighty":-1.649005,"marketCap":14894366},{"date":"2023-11-10","current":-0.44005,"twenty":-8.49247,"median":-3.599435,"eighty":-1.632997,"marketCap":13135095},{"date":"2023-11-17","current":-0.449421,"twenty":-8.49247,"median":-3.599435,"eighty":-1.621882,"marketCap":14163318},{"date":"2023-11-24","current":-0.529069,"twenty":-8.49247,"median":-3.599435,"eighty":-1.614381,"marketCap":16641750},{"date":"2023-12-01","current":-0.457266,"twenty":-8.49247,"median":-3.599435,"eighty":-1.595199,"marketCap":14383226},{"date":"2023-12-08","current":-0.434592,"twenty":-8.490003,"median":-3.59797,"eighty":-1.577064,"marketCap":13670009},{"date":"2023-12-15","current":-0.421365,"twenty":-8.490003,"median":-3.59797,"eighty":-1.555884,"marketCap":13253965},{"date":"2023-12-22","current":-0.394912,"twenty":-8.490003,"median":-3.59797,"eighty":-1.542198,"marketCap":12421877},{"date":"2023-12-29","current":-0.434592,"twenty":-8.49247,"median":-3.599435,"eighty":-1.511616,"marketCap":13670009},{"date":"2024-01-05","current":-0.434592,"twenty":-8.494936,"median":-3.605917,"eighty":-1.486894,"marketCap":13670009},{"date":"2024-01-12","current":-0.409083,"twenty":-8.494936,"median":-3.605917,"eighty":-1.471591,"marketCap":12867638},{"date":"2024-01-19","current":-0.390377,"twenty":-8.497403,"median":-3.612398,"eighty":-1.402651,"marketCap":12279234},{"date":"2024-01-26","current":-0.430435,"twenty":-8.494936,"median":-3.605917,"eighty":-1.372291,"marketCap":13539252},{"date":"2024-02-02","current":-0.346729,"twenty":-8.494936,"median":-3.605917,"eighty":-1.339755,"marketCap":10906285},{"date":"2024-02-09","current":-0.208321,"twenty":-8.494936,"median":-3.605917,"eighty":-1.314773,"marketCap":6552686},{"date":"2024-02-16","current":-0.206904,"twenty":-8.494936,"median":-3.605917,"eighty":-1.284337,"marketCap":6508110},{"date":"2024-02-23","current":-0.207848,"twenty":-8.494936,"median":-3.605917,"eighty":-1.265892,"marketCap":6537828},{"date":"2024-03-01","current":-0.203124,"twenty":-8.49247,"median":-3.599435,"eighty":-1.254668,"marketCap":6389241},{"date":"2024-03-08","current":-0.200763,"twenty":-8.49247,"median":-3.599435,"eighty":-1.240197,"marketCap":6314947},{"date":"2024-03-15","current":-0.196511,"twenty":-8.49247,"median":-3.599435,"eighty":-1.229176,"marketCap":6181219},{"date":"2024-03-22","current":-0.142659,"twenty":-8.49247,"median":-3.599435,"eighty":-1.224346,"marketCap":4487327},{"date":"2024-03-28","current":-0.128016,"twenty":-8.49247,"median":-3.599435,"eighty":-1.215365,"marketCap":4026707},{"date":"2024-04-05","current":-0.185098,"twenty":-8.494936,"median":-3.605917,"eighty":-1.202437,"marketCap":5712218},{"date":"2024-04-12","current":-0.172098,"twenty":-8.494936,"median":-3.605917,"eighty":-1.194249,"marketCap":5311025},{"date":"2024-04-19","current":-0.137394,"twenty":-8.494936,"median":-3.605917,"eighty":-1.157359,"marketCap":4240032},{"date":"2024-04-26","current":-0.13124,"twenty":-8.49247,"median":-3.599435,"eighty":-1.104089,"marketCap":4050134},{"date":"2024-05-03","current":-0.160494,"twenty":-8.49247,"median":-3.599435,"eighty":-1.06657,"marketCap":4952927},{"date":"2024-05-10","current":-0.165255,"twenty":-8.49247,"median":-3.599435,"eighty":-1.034736,"marketCap":5099836},{"date":"2024-05-17","current":-0.183839,"twenty":-8.49247,"median":-3.599435,"eighty":-1.01129,"marketCap":5078849},{"date":"2024-05-24","current":-0.167634,"twenty":-8.49247,"median":-3.599435,"eighty":-0.977772,"marketCap":4631154},{"date":"2024-05-31","current":-0.183563,"twenty":-8.49247,"median":-3.599435,"eighty":-0.959893,"marketCap":5071218},{"date":"2024-06-07","current":-0.207457,"twenty":-8.49247,"median":-3.599435,"eighty":-0.925746,"marketCap":5731315},{"date":"2024-06-14","current":-0.183563,"twenty":-8.494936,"median":-3.605917,"eighty":-0.896806,"marketCap":5071218},{"date":"2024-06-21","current":-0.155498,"twenty":-8.497403,"median":-3.612398,"eighty":-0.856995,"marketCap":4295867},{"date":"2024-06-28","current":-0.14943,"twenty":-8.500834,"median":-3.612398,"eighty":-0.789805,"marketCap":4128223},{"date":"2024-07-05","current":-0.144878,"twenty":-8.500834,"median":-3.612398,"eighty":-0.75175,"marketCap":4002490},{"date":"2024-07-12","current":-0.139569,"twenty":-8.500834,"median":-3.612398,"eighty":-0.725518,"marketCap":3855802},{"date":"2024-07-15","current":-0.145637,"twenty":-8.500834,"median":-3.612398,"eighty":-0.722479,"marketCap":4023446},{"date":"2024-08-02","current":-0.127432,"twenty":-8.515816,"median":-3.637837,"eighty":-0.700599,"marketCap":3520515},{"date":"2024-08-09","current":-0.107711,"twenty":-8.515816,"median":-3.637837,"eighty":-0.696618,"marketCap":2975673},{"date":"2024-08-16","current":-0.06455,"twenty":-8.515816,"median":-3.637837,"eighty":-0.6831,"marketCap":1687473},{"date":"2024-08-23","current":-0.096384,"twenty":-8.515816,"median":-3.637837,"eighty":-0.664031,"marketCap":2519695},{"date":"2024-08-30","current":-0.092434,"twenty":-8.515816,"median":-3.637837,"eighty":-0.649115,"marketCap":2416417},{"date":"2024-09-06","current":-0.068688,"twenty":-8.515816,"median":-3.637837,"eighty":-0.635185,"marketCap":1795669},{"date":"2024-09-13","current":-0.05919,"twenty":-8.515816,"median":-3.637837,"eighty":-0.628095,"marketCap":1547370},{"date":"2024-09-20","current":-0.053684,"twenty":-8.515816,"median":-3.637837,"eighty":-0.596902,"marketCap":1403429},{"date":"2024-09-27","current":-0.048109,"twenty":-8.515816,"median":-3.637837,"eighty":-0.58349,"marketCap":1257688},{"date":"2024-10-04","current":-0.045425,"twenty":-8.515816,"median":-3.637837,"eighty":-0.530036,"marketCap":1187517},{"date":"2024-10-11","current":-0.046774,"twenty":-8.515816,"median":-3.637837,"eighty":-0.525687,"marketCap":1222782},{"date":"2024-10-18","current":-0.046788,"twenty":-8.515816,"median":-3.637837,"eighty":-0.498907,"marketCap":1223142},{"date":"2024-10-25","current":-0.294576,"twenty":-8.515816,"median":-3.637837,"eighty":-0.489223,"marketCap":7700869},{"date":"2024-10-31","current":-0.278058,"twenty":-8.515816,"median":-3.637837,"eighty":-0.475673,"marketCap":7269044},{"date":"2024-11-08","current":-0.232632,"twenty":-8.51619,"median":-3.637837,"eighty":-0.467657,"marketCap":6081527},{"date":"2024-11-15","current":-0.259868,"twenty":-8.51619,"median":-3.637837,"eighty":-0.459349,"marketCap":5901600},{"date":"2024-11-22","current":-0.18064,"twenty":-8.51619,"median":-3.637837,"eighty":-0.455934,"marketCap":4102332},{"date":"2024-11-29","current":-0.408358,"twenty":-8.51619,"median":-3.637837,"eighty":-0.454848,"marketCap":9273794},{"date":"2024-12-06","current":-0.404612,"twenty":-8.51619,"median":-3.637837,"eighty":-0.447819,"marketCap":9188713},{"date":"2024-12-13","current":-0.397119,"twenty":-8.51619,"median":-3.637837,"eighty":-0.445625,"marketCap":9018552},{"date":"2024-12-20","current":-0.337176,"twenty":-8.51619,"median":-3.637837,"eighty":-0.443656,"marketCap":7657261},{"date":"2024-12-27","current":-0.33343,"twenty":-8.51619,"median":-3.637837,"eighty":-0.443656,"marketCap":7572180},{"date":"2025-01-03","current":-0.337514,"twenty":-8.51619,"median":-3.637837,"eighty":-0.44005,"marketCap":7664918},{"date":"2025-01-10","current":-0.288885,"twenty":-8.516564,"median":-3.637837,"eighty":-0.434592,"marketCap":6560571},{"date":"2025-01-17","current":-0.262248,"twenty":-8.516564,"median":-3.637837,"eighty":-0.430359,"marketCap":5955647},{"date":"2025-01-24","current":-0.264122,"twenty":-8.516564,"median":-3.637837,"eighty":-0.419173,"marketCap":5998187},{"date":"2025-01-31","current":-0.228531,"twenty":-8.516564,"median":-3.62471,"eighty":-0.411879,"marketCap":5189921},{"date":"2025-02-07","current":-0.18732,"twenty":-8.516564,"median":-3.621481,"eighty":-0.408358,"marketCap":4254034},{"date":"2025-02-14","current":-0.176456,"twenty":-8.516564,"median":-3.612398,"eighty":-0.404058,"marketCap":4007300},{"date":"2025-02-21","current":-0.14817,"twenty":-8.49247,"median":-3.596505,"eighty":-0.399258,"marketCap":3364940},{"date":"2025-02-28","current":-0.14049,"twenty":-8.420685,"median":-3.561119,"eighty":-0.394912,"marketCap":3190525},{"date":"2025-03-07","current":-0.125505,"twenty":-8.382425,"median":-3.53608,"eighty":-0.389926,"marketCap":2850202},{"date":"2025-03-14","current":-0.134908,"twenty":-8.382425,"median":-3.51064,"eighty":-0.364966,"marketCap":3063755},{"date":"2025-03-21","current":-0.14064,"twenty":-8.370864,"median":-3.479453,"eighty":-0.343245,"marketCap":3193928},{"date":"2025-03-28","current":-0.128127,"twenty":-8.370864,"median":-3.453207,"eighty":-0.330126,"marketCap":2909759},{"date":"2025-04-04","current":-0.171687,"twenty":-8.370864,"median":-3.421602,"eighty":-0.317305,"marketCap":3672082},{"date":"2025-04-11","current":-0.299253,"twenty":-8.367064,"median":-3.383468,"eighty":-0.297933,"marketCap":6400504},{"date":"2025-04-17","current":-0.288525,"twenty":-8.367064,"median":-3.371724,"eighty":-0.294188,"marketCap":6171052},{"date":"2025-04-25","current":-0.300947,"twenty":-8.370864,"median":-3.353576,"eighty":-0.288026,"marketCap":6436733},{"date":"2025-05-02","current":-0.310884,"twenty":-8.370864,"median":-3.332564,"eighty":-0.288026,"marketCap":6649279},{"date":"2025-05-09","current":-0.323984,"twenty":-8.291247,"median":-3.292403,"eighty":-0.288026,"marketCap":6929452},{"date":"2025-05-16","current":-0.295057,"twenty":-8.281861,"median":-3.278689,"eighty":-0.285135,"marketCap":5719394},{"date":"2025-05-23","current":-0.3287,"twenty":-8.281861,"median":-3.263487,"eighty":-0.285135,"marketCap":6371521},{"date":"2025-05-30","current":-0.414924,"twenty":-8.281861,"median":-3.246845,"eighty":-0.285135,"marketCap":8042898},{"date":"2025-06-06","current":-0.339914,"twenty":-8.281861,"median":-3.196134,"eighty":-0.285135,"marketCap":6588896},{"date":"2025-06-13","current":-0.390128,"twenty":-8.281861,"median":-3.167502,"eighty":-0.285135,"marketCap":7562256},{"date":"2025-06-20","current":-0.45194,"twenty":-8.280352,"median":-3.11951,"eighty":-0.284282,"marketCap":8760414},{"date":"2025-06-27","current":-0.350179,"twenty":-8.208524,"median":-3.095514,"eighty":-0.284282,"marketCap":6787870},{"date":"2025-07-03","current":-0.389537,"twenty":-8.161542,"median":-3.071518,"eighty":-0.284282,"marketCap":7550781},{"date":"2025-07-11","current":-0.435329,"twenty":-8.107477,"median":-3.022063,"eighty":-0.284282,"marketCap":8438425},{"date":"2025-07-18","current":-0.424255,"twenty":-8.0232,"median":-2.936322,"eighty":-0.284282,"marketCap":8223766},{"date":"2025-07-25","current":-0.488181,"twenty":-7.893378,"median":-2.861613,"eighty":-0.284282,"marketCap":9462911},{"date":"2025-08-01","current":-0.394991,"twenty":-7.832142,"median":-2.819219,"eighty":-0.284282,"marketCap":7656506},{"date":"2025-08-08","current":-0.378576,"twenty":-7.672084,"median":-2.776825,"eighty":-0.284282,"marketCap":7338313},{"date":"2025-08-15","current":-0.369342,"twenty":-7.547318,"median":-2.755628,"eighty":-0.284282,"marketCap":7159330},{"date":"2025-08-22","current":-0.274014,"twenty":-7.45155,"median":-2.692036,"eighty":-0.28207,"marketCap":4812523},{"date":"2025-08-29","current":-0.332894,"twenty":-7.38144,"median":-2.653034,"eighty":-0.28207,"marketCap":5846647},{"date":"2025-09-05","current":-0.296689,"twenty":-7.330145,"median":-2.607248,"eighty":-0.28173,"marketCap":5210778},{"date":"2025-09-12","current":-0.492577,"twenty":-7.275425,"median":-2.501262,"eighty":-0.28207,"marketCap":8651163},{"date":"2025-09-19","current":-0.597296,"twenty":-7.196402,"median":-2.423469,"eighty":-0.28207,"marketCap":10490355},{"date":"2025-09-26","current":-0.452553,"twenty":-7.062659,"median":-2.215101,"eighty":-0.28207,"marketCap":7948214},{"date":"2025-10-03","current":-0.488586,"twenty":-6.979987,"median":-2.133421,"eighty":-0.28207,"marketCap":8581067},{"date":"2025-10-10","current":-0.565049,"twenty":-6.810605,"median":-2.087312,"eighty":-0.28207,"marketCap":9924004},{"date":"2025-10-17","current":-1.161613,"twenty":-6.627287,"median":-2.064601,"eighty":-0.28207,"marketCap":20401488},{"date":"2025-10-24","current":-0.447544,"twenty":-6.347648,"median":-1.956252,"eighty":-0.28207,"marketCap":7860250},{"date":"2025-10-31","current":-0.358543,"twenty":-6.064113,"median":-1.897369,"eighty":-0.28207,"marketCap":6297124},{"date":"2025-11-07","current":-0.268193,"twenty":-5.983017,"median":-1.82408,"eighty":-0.278282,"marketCap":4710288},{"date":"2025-11-14","current":-0.294195,"twenty":-5.911299,"median":-1.805771,"eighty":-0.278282,"marketCap":5166964},{"date":"2025-11-21","current":-0.302506,"twenty":-5.864116,"median":-1.790585,"eighty":-0.278058,"marketCap":5156617},{"date":"2025-11-28","current":-0.28336,"twenty":-5.789375,"median":-1.784408,"eighty":-0.277901,"marketCap":4830249},{"date":"2025-12-05","current":-0.446176,"twenty":-5.694467,"median":-1.766235,"eighty":-0.27676,"marketCap":7605659},{"date":"2025-12-12","current":-0.431525,"twenty":-5.669491,"median":-1.753755,"eighty":-0.27676,"marketCap":7355921},{"date":"2025-12-19","current":-0.295196,"twenty":-5.644515,"median":-1.739748,"eighty":-0.27676,"marketCap":5031999},{"date":"2025-12-26","current":-0.253025,"twenty":-5.617016,"median":-1.698553,"eighty":-0.273449,"marketCap":4313142},{"date":"2026-01-02","current":-0.238061,"twenty":-5.544612,"median":-1.689166,"eighty":-0.270337,"marketCap":4058064},{"date":"2026-01-09","current":-0.27207,"twenty":-5.519637,"median":-1.63648,"eighty":-0.268073,"marketCap":4637788},{"date":"2026-01-16","current":-0.448915,"twenty":-5.486249,"median":-1.627075,"eighty":-0.268073,"marketCap":7652350},{"date":"2026-01-23","current":-0.398582,"twenty":-5.349888,"median":-1.612436,"eighty":-0.268073,"marketCap":6794359},{"date":"2026-01-30","current":-0.334646,"twenty":-5.314836,"median":-1.571587,"eighty":-0.268073,"marketCap":5704479},{"date":"2026-02-06","current":-0.266628,"twenty":-5.191958,"median":-1.541273,"eighty":-0.266911,"marketCap":4545032},{"date":"2026-02-13","current":-0.277511,"twenty":-5.120025,"median":-1.485623,"eighty":-0.266911,"marketCap":4730543},{"date":"2026-02-20","current":-0.253025,"twenty":-5.045098,"median":-1.467001,"eighty":-0.262309,"marketCap":4313142},{"date":"2026-02-27","current":-0.289754,"twenty":-4.990151,"median":-1.389503,"eighty":-0.262248,"marketCap":4939244},{"date":"2026-03-06","current":-0.27207,"twenty":-4.920219,"median":-1.228031,"eighty":-0.262248,"marketCap":4637788},{"date":"2026-03-13","current":-0.266628,"twenty":-4.838928,"median":-1.098666,"eighty":-0.262248,"marketCap":4545032},{"date":"2026-03-20","current":-0.261187,"twenty":-4.709705,"median":-1.034378,"eighty":-0.262248,"marketCap":4452276},{"date":"2026-03-27","current":-0.255745,"twenty":-4.565564,"median":-0.964517,"eighty":-0.259835,"marketCap":4359520},{"date":"2026-04-02","current":-0.22576,"twenty":-4.345285,"median":-0.914361,"eighty":-0.257106,"marketCap":3663852},{"date":"2026-04-10","current":-0.724527,"twenty":-4.223337,"median":-0.886894,"eighty":-0.257106,"marketCap":11758312},{"date":"2026-04-17","current":-0.724527,"twenty":-4.080458,"median":-0.792353,"eighty":-0.257106,"marketCap":11758312},{"date":"2026-04-24","current":-0.578568,"twenty":-4.053264,"median":-0.756527,"eighty":-0.257106,"marketCap":9389545},{"date":"2026-05-01","current":-0.553043,"twenty":-3.979888,"median":-0.7301,"eighty":-0.257106,"marketCap":8975301},{"date":"2026-05-08","current":-0.490648,"twenty":-3.941171,"median":-0.700599,"eighty":-0.257106,"marketCap":7962703},{"date":"2026-05-15","current":-0.536433,"twenty":-3.881672,"median":-0.695716,"eighty":-0.257106,"marketCap":8972506},{"date":"2026-05-22","current":-0.507596,"twenty":-3.841353,"median":-0.656811,"eighty":-0.257106,"marketCap":8490181},{"date":"2026-05-29","current":-0.502983,"twenty":-3.815401,"median":-0.642321,"eighty":-0.257106,"marketCap":8413013},{"date":"2026-06-05","current":-0.43988,"twenty":-3.790474,"median":-0.607488,"eighty":-0.257106,"marketCap":7357549},{"date":"2026-06-12","current":-0.413677,"twenty":-3.762407,"median":-0.578568,"eighty":-0.257106,"marketCap":6919272},{"date":"2026-06-18","current":-0.305954,"twenty":-3.739595,"median":-0.565049,"eighty":-0.257106,"marketCap":5117466},{"date":"2026-06-26","current":-0.298169,"twenty":-3.714156,"median":-0.554442,"eighty":-0.257106,"marketCap":4987253},{"date":"2026-07-02","current":-0.33817,"twenty":-3.69542,"median":-0.537183,"eighty":-0.257106,"marketCap":5656314},{"date":"2026-07-10","current":-0.351588,"twenty":-3.671432,"median":-0.529352,"eighty":-0.257106,"marketCap":5880746},{"date":"2026-07-17","current":-0.230153,"twenty":-3.637837,"median":-0.52246,"eighty":-0.255745,"marketCap":3849592},{"date":"2026-07-24","current":-0.21548,"twenty":-3.637837,"median":-0.50709,"eighty":-0.253025,"marketCap":3604180},{"date":"2026-07-31","current":-0.174341,"twenty":-3.612398,"median":-0.502106,"eighty":-0.251254,"marketCap":2916065},{"date":"2026-08-07","current":-0.127735,"twenty":-3.597091,"median":-0.494205,"eighty":-0.243502,"marketCap":2136523},{"date":"2026-08-14","current":-0.140105,"twenty":-3.561199,"median":-0.491964,"eighty":-0.239421,"marketCap":2343439},{"date":"2026-08-21","current":-0.115206,"twenty":-3.53608,"median":-0.490144,"eighty":-0.235247,"marketCap":1900736},{"date":"2026-08-28","current":-0.179358,"twenty":-3.51064,"median":-0.486932,"eighty":-0.230872,"marketCap":2959149},{"date":"2026-09-04","current":-0.170166,"twenty":-3.483068,"median":-0.469531,"eighty":-0.227347,"marketCap":2807503},{"date":"2026-09-11","current":-0.16644,"twenty":-3.459762,"median":-0.465781,"eighty":-0.220717,"marketCap":2746025}],"updateTime":1789279321988},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNPX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643921368","title":"Genprex faces Nasdaq delisting risk after bid price stays below $1","url":"https://stock-news.laohu8.com/highlight/detail?id=2643921368","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643921368?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:06","pubTimestamp":1781298406,"startTime":"0","endTime":"0","summary":"Genprex received a Nasdaq notice on June 10, 2026, citing noncompliance with the $1 minimum bid price rule after 30 straight business-day closes below $1.Nasdaq staff moved to delist the stock, citing ineligibility for a standard compliance period due to a reverse split on Oct. 21, 2025.A timely hearing request will stay any suspension or delisting while a Nasdaq panel reviews the case.Regaining compliance requires a closing bid of at least $1 for 10 consecutive business days, subject to panel discretion.Options include another reverse stock split; delisting could pressure the share price, reduce liquidity, and hinder access to capital markets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content u","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL6jNY69:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641512831","title":"Genprex files $250M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2641512831","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641512831?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:05","pubTimestamp":1780693510,"startTime":"0","endTime":"0","summary":"17:03 EDT Genprex (GNPX) files $250M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-files-250m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-files-250m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641735140","title":"Genprex Inc Files for Mixed Shelf of up to $250 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641735140","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641735140?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:03","pubTimestamp":1780693408,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D0RU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511794","title":"Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 Asco Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511794?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:00","pubTimestamp":1779796817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA9MTZ0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635744191","title":"Genprex collaborators present positive preclinical data of GPX-002 in diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2635744191","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635744191?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:54","pubTimestamp":1778777695,"startTime":"0","endTime":"0","summary":"Genprex’s (GNPX) research collaborators presented positive preclinical data on the company’s diabetes gene therapy drug candidate at the 2026 Ameri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-collaborators-present-positive-preclinical-data-of-gpx-002-in-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-collaborators-present-positive-preclinical-data-of-gpx-002-in-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GPX","BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635187755","title":"Genprex Q1 net loss widens 13% to $4.46 million year over year","url":"https://stock-news.laohu8.com/highlight/detail?id=2635187755","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635187755?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:36","pubTimestamp":1778704600,"startTime":"0","endTime":"0","summary":"Genprex posted a net loss of USD 4.46 million for the quarter ended March 31, 2026, widening 13% from the year-earlier period.Research and development expense rose 8% to USD 2.75 million, while general and administrative costs climbed 22% to USD 1.75 million.Other income increased to USD 31,748, while cash and cash equivalents totaled USD 18.05 million as of March 31, 2026.During the quarter, 5,714,798 shares were sold under the 2023 at-the-market facility for net proceeds of about USD 13.36 million.Operationally, Genprex continued enrolling Acclaim-1 and Acclaim-3, targeting interim enrollments in the first half of 2026 with interim analyses expected in the second half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex In","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL4NqTkN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631162634","title":"Genprex Receives Patent Grant From the Israel Patent Office for the Combination of Reqorsa® Gene Therapy and Pd-1 Antibodies to Treat Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2631162634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631162634?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:09","pubTimestamp":1777550972,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41D0R7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631634687","title":"Genprex says Israel grants patent for Reqorsa plus PD-1 antibody cancer treatment combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2631634687","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631634687?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:01","pubTimestamp":1777550470,"startTime":"0","endTime":"0","summary":"Genprex received patent grant from Israel Patent Office covering use of Reqorsa gene therapy with PD-1 antibodies to treat cancer.Grant expands Genprex intellectual property protection for this combination in Israel, adding to patents already issued in major markets.Reqorsa is being developed in combination regimens for lung cancer, with clinical programs in NSCLC and SCLC.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDLpyJy8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630303262","title":"Genprex says diabetes gene therapy reverses hyperglycemia in preclinical Type 2 models","url":"https://stock-news.laohu8.com/highlight/detail?id=2630303262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630303262?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:04","pubTimestamp":1777374287,"startTime":"0","endTime":"0","summary":"Genprex disclosed that collaborators will present new preclinical results for its GPX-002  diabetes gene therapy at ASGCT 2026 on May 13.Data to be presented show treatment reversed high blood sugar in Type 2 diabetic mouse models within four weeks.Researchers also reported improved insulin-producing cell function and signs of more mature insulin production in treated animals.Genprex highlighted a potential delivery path to humans using an endoscopic procedure to infuse therapy directly into pancreas.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire  on April 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL3tM505:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010463","title":"Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy to Be Released at the 2026 Asco Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010463?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855610,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUA6NYP6M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629911033","title":"Genprex signs MD Anderson research deal to study Reqorsa lung cancer response biomarkers","url":"https://stock-news.laohu8.com/highlight/detail?id=2629911033","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629911033?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:07","pubTimestamp":1776769634,"startTime":"0","endTime":"0","summary":"Genprex on April 21, 2026 signed sponsored research agreement with UT MD Anderson to study biomarkers that could predict response to its Reqorsa gene therapy in lung cancer.Findings have not been presented; work will be used to guide future patient selection for Acclaim-1 and Acclaim-3 clinical trials.Genprex expects biomarker work to help identify patients more likely to benefit from Reqorsa, aiming to improve trial outcomes without changing current trial design disclosures.Update follows earlier Acclaim-1 and Acclaim-3 Phase 1 results already presented internally by Genprex as showing tolerability with early signs of benefit in some patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content u","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL9v0vsW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629038267","title":"Genprex Signs Sponsored Research Agreement to Study Biomarkers That May Predict Patient Response to Reqorsa® Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2629038267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629038267?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:00","pubTimestamp":1776769210,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUAPWCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628374257","title":"Genprex says Reqorsa gene therapy data support potential ALK+ NSCLC clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628374257","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628374257?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:01","pubTimestamp":1776682895,"startTime":"0","endTime":"0","summary":"Genprex reported positive preclinical results for Reqorsa gene therapy in lung cancer studies presented at 2026 AACR Annual Meeting.Data indicated Reqorsa reduced tumor growth in ALK-positive non-small cell lung cancer models, including settings with resistance to existing ALK inhibitors.Separate findings pointed to TROP2 and PTEN as potential biomarkers to identify patients less likely to respond, supporting a more targeted clinical development strategy.Additional preclinical work showed Reqorsa boosted natural killer cell anti-tumor activity, with tumor suppression observed in animal models.Genprex highlighted these results as support for moving toward a future clinical trial, including a potential program in ALK-positive disease.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL5wQkzM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628742846","title":"Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 Aacr Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628742846","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628742846?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:00","pubTimestamp":1776682803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nTUA3FGMPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628849077","title":"Genprex announces annual shareholder meeting webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2628849077","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628849077?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:36","pubTimestamp":1776458171,"startTime":"0","endTime":"0","summary":"Genprex will hold its 2026 annual stockholders meeting virtually on June 18, 2026.Items up for stockholder vote include election of two Class III directors.Additional proposals cover ratification of WithumSmith+Brown as independent auditor for fiscal 2026.Stockholders will also vote on an amended and restated 2018 Equity Incentive Plan.Other proposals include a charter amendment authorizing a reverse stock split at a ratio ranging from 1-for-5 to 1-for-50, plus authorization to adjourn meeting if needed to solicit additional proxies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL9q8RKh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627255737","title":"Genprex director Brent Longnecker disposes of USD 22 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2627255737","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627255737?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:51","pubTimestamp":1776293485,"startTime":"0","endTime":"0","summary":"Genprex director Brent Longnecker sold 8 shares of common stock on April 14, 2026 at USD 1.23 per share.Longnecker Associates Ltd, an indirect holder, sold 10 shares at USD 1.23 per share, reducing its position to zero shares.Brent Longnecker reported direct ownership of 9,157 Genprex shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL1xCFGv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983260115.SGD","BK4588","LU2265009873.SGD","SGXZ31699556.SGD","SG9999014914.USD","LU0251131958.USD","SG9999014880.SGD","LU0077335932.USD","SG9999018865.SGD","SG9999017495.SGD","IE00BFXG1179.USD","BK4585","LU0048573561.USD","LU0742534661.SGD","LU0157215616.USD","SG9999014906.USD","LU1691799644.USD","SG9999018857.SGD","LU1804176565.USD","BK4139","BK4559","BK4173","BK4532","SG9999014898.SGD","LU0251142724.SGD","AON","LU2236285917.USD","LU1366333091.USD","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623971324","title":"Genprex FY25 net loss narrows 23% to $16M","url":"https://stock-news.laohu8.com/highlight/detail?id=2623971324","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623971324?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:42","pubTimestamp":1774906935,"startTime":"0","endTime":"0","summary":"Genprex posted a net loss of USD 16.2 million in fiscal 2025, narrowing 23%.Research and development expense fell 11% to USD 9.4 million due to Acclaim-2 closure and lower clinical and manufacturing costs.General and administrative expense dropped 43% to USD 6.1 million on lower share-based compensation and cost-cutting.Cash totaled USD 7.8 million at Dec. 31, 2025; net cash used in operating activities improved to USD 15.3 million.Genprex expects to complete interim enrollment for Acclaim-1 and Acclaim-3 in first-half 2026, with interim analyses in second-half 2026, and forecasts cash runway into second-quarter 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL9wXfDp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620237926","title":"Genprex collaborators to present Reqorsa lung cancer preclinical data at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620237926","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620237926?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:02","pubTimestamp":1773831749,"startTime":"0","endTime":"0","summary":"Genprex said its collaborators will present preclinical data on Reqorsa  for lung cancer at the 2026 AACR Annual Meeting on April 19, 2026. One poster reports that low TROP2 and high PTEN expression were identified as potential biomarkers associated with primary resistance to TUSC2 gene therapy in non-small cell lung cancer models. Another poster describes studies in ALK-positive non-small cell lung cancer showing 79% tumor shrinkage with Reqorsa alone or with alectinib in an alectinib-sensitive mouse model, compared with 60% tumor shrinkage with alectinib alone. A third poster reports that restoring TUSC2 function increased natural killer cell cytotoxicity and led to complete tumor regression in 67% of Tusc2 knockout mice and 33% of wild-type mice in a syngeneic tumor model.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL5mBPvy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":38,"code":"91000000","status":"200"}]}}